Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BLUEPRINT INVESTMENT PARTNERS LLC | 02-13-2024 | 12-31-2023 | 136 | 363,070,615 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Merck & Co Inc | Stock | 551 | $456,134 | 4,183 | 0.00 | 4,183 | +Inf | 12-31-2023 | |
| Xylem Inc | Stock/ETF | Liquidated | $0 | 0 | 0.00 | 4,041 | +Inf | 12-31-2023 | |
| Gilead Sciences Inc | Stock/ETF | Liquidated | $0 | 0 | 0.00 | 5,864 | +Inf | 12-31-2023 | |
| BlackRock Inc | Stock/ETF | Liquidated | $0 | 0 | 0.00 | 651 | +Inf | 12-31-2023 |
